These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 25329914)
21. Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors. Li M; Zhao L; Zhang C; Wang X; Hong W; Sun J; Liu R; Yu L; Wang J; Zhang F; Jin X PLoS One; 2018; 13(7):e0200478. PubMed ID: 30044839 [TBL] [Abstract][Full Text] [Related]
22. Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein. Tang CT; Liao MY; Chiu CY; Shen WF; Chiu CY; Cheng PC; Chang GJ; Wu HC PLoS One; 2015; 10(8):e0136328. PubMed ID: 26309127 [TBL] [Abstract][Full Text] [Related]
23. Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection. Wegman AD; Fang H; Rothman AL; Thomas SJ; Endy TP; McCracken MK; Currier JR; Friberg H; Gromowski GD; Waickman AT Front Immunol; 2021; 12():777672. PubMed ID: 34899736 [TBL] [Abstract][Full Text] [Related]
24. Molecular Simulations Reveal the Role of Antibody Fine Specificity and Viral Maturation State on Antibody-Dependent Enhancement of Infection in Dengue Virus. Ripoll DR; Wallqvist A; Chaudhury S Front Cell Infect Microbiol; 2019; 9():200. PubMed ID: 31275864 [TBL] [Abstract][Full Text] [Related]
25. Mast cell-macrophage dynamics in modulation of dengue virus infection in skin. Chu YT; Wan SW; Anderson R; Lin YS Immunology; 2015 Sep; 146(1):163-72. PubMed ID: 26059780 [TBL] [Abstract][Full Text] [Related]
26. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice. Frei JC; Wirchnianski AS; Govero J; Vergnolle O; Dowd KA; Pierson TC; Kielian M; Girvin ME; Diamond MS; Lai JR J Virol; 2018 Sep; 92(18):. PubMed ID: 29976679 [TBL] [Abstract][Full Text] [Related]
27. Dengue virus exploits autophagy vesicles and secretory pathways to promote transmission by human dendritic cells. Cloherty APM; Rader AG; Patel KS; Eisden TTHD; van Piggelen S; Schreurs RRCE; Ribeiro CMS Front Immunol; 2024; 15():1260439. PubMed ID: 38863700 [TBL] [Abstract][Full Text] [Related]
28. The human antibody response to dengue virus infection. Wahala WM; Silva AM Viruses; 2011 Dec; 3(12):2374-95. PubMed ID: 22355444 [TBL] [Abstract][Full Text] [Related]
36. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice. Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279 [TBL] [Abstract][Full Text] [Related]
37. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes. Uno N; Ross TM J Virol; 2021 Jan; 95(4):. PubMed ID: 33208445 [TBL] [Abstract][Full Text] [Related]
38. Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Schieffelin JS; Costin JM; Nicholson CO; Orgeron NM; Fontaine KA; Isern S; Michael SF; Robinson JE Virol J; 2010 Feb; 7():28. PubMed ID: 20132551 [TBL] [Abstract][Full Text] [Related]
39. Human monoclonal single-chain antibodies specific to dengue virus envelope protein. Saokaew N; Poungpair O; Panya A; Tarasuk M; Sawasdee N; Limjindaporn T; Chaicumpa W; Yenchitsomanus P Lett Appl Microbiol; 2014 Mar; 58(3):270-7. PubMed ID: 24266517 [TBL] [Abstract][Full Text] [Related]
40. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus. Ito M; Mukai RZ; Takasaki T; Kotaki A; Kurane I Arch Virol; 2010 Oct; 155(10):1617-24. PubMed ID: 20644969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]